Catalog

FGFR Fibroblast Growth Factor Receptor

Inhibitors

Cat.No.	Name	Information
M10518	ASP5878	ASP5878 is a novel selective FGFR inhibitor with IC50 values of 0.47 nM, 0.6 nM, 0.74 nM and 3.5 nM for FGFR 1, 2, 3 and 4, respectively.
M10048	PF-05231023	PF-05231023 is an FGF21-receptor agonist, it is also a potential treatment for T2DM.
M10026	Futibatinib (TAS-120)	Futibatinib, also known as TAS-120 is an orally bioavailable irreversible inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity.
M9715	Erdafitinib	Erdafitinib (JNJ-42756493) is a potent and selective orally bioavailable, pan FGFR inhibitor with potential antineoplastic activity.
M9596	Pemigatinib	Pemigatinib (INCB054828) is an orally bioavailable inhibitor of FGFR with IC50s of 0.4 nM, 0.5 nM, 1.2 nM, 30 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively.
M9532	BO-264	BO-264 is a highly potent and orally active transforming acidic coiled-coil 3 (TACC3) inhibitor with an IC50 of 188 nM and a Kd of 1.5 nM.
M9296	2,5-Dihydroxybenzoic acid	2,5-Dihydroxybenzoic acid is a derivative of benzoic, it is also an inhibitor of fibroblast growth factors.
M8938	FIIN-3	FIIN-3 is a potent, selective, irreversible and the next-generation covalent FGFR inhibitor with IC50 values of 13.1, 21, 31.4 and 35.3 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively.
M8936	FGFR4-IN-1	FGFR4-IN-1 is a potent and selective FGFR4 inhibitor with IC50 of 0.7 nM.
M6158	ARQ-087	ARQ 087 is a novel, ATP competitive, small molecule, multi-kinase inhibitor with potent in vitro and in vivo activity against FGFR addicted cell lines and tumors. ARQ 087 exhibited IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3.
M6095	FGF-401	FGF-401 is an inhibitor of FGFR4, with an IC50 of 1.9 nM.
M5274	PD-166866 (PD166866)	PD-166866 is a synthetic molecule inhibiting the tyrosin kinase action of FGFR1, shows a very high selectivity towards FGFR1 and inhibits the auto-phosphorylation activity of FGRF1.
M5253	BLU-9931	BLU9931 is a potent, selective, and irreversible FGFR4 inhibitor with IC50 of 3 nM, about 297-, 184-, and 50-fold selectivity over FGFR1/2/3, respectively.
M5242	H3B-6527	H3B-6527 (H3 Biomedicine) is a highly selective FGFR4 inhibitor with potent antitumour activity in FGF19 amplified cell lines and mice.
M5237	Fisogatinib (BLU-554)	Fisogatinib (BLU-554) is a potent, highly-selective, oral FGFR4 inhibitor with an IC50 value of 5 nM. The IC50s for FGFR1-3 is 624-2203 nM.
M5235	NSC12	NSC12 is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity.
M4977	AZ5104	AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor with IC50 of <1 nM, 6 nM, 1 nM, and 25 nM for EGFR (L858R/T790M), EGFR (L858R), EGFR (L861Q), and EGFR (wildtype), respectively.
M3897	Ferulic Acid	Ferulic Acid is a hydroxycinnamic acid and a type of organic compound found in the Ferula assafoetida L. or Ligusticum chuanxiong.
M3698	SKLB610	SKLB610 is a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
M3617	LY2874455	LY2874455 is a novel and potent FGF/FGFR inhibitor.
M3031	SSR128129E	SSR128129E is an orally-active and allosteric FGFR1 inhibitor with IC50 of 1.9 μM, while not affecting other related RTKs.
M1875	PD173074	PD173074 is a selective FGFR1 and FGFR3 inhibitor with IC50 values of 5, 21.5, ~100, 17600 and 19800 nM for FGFR3, FGFR1, VEGFR2, PDGFR and c-Src respectively.
M1840	BGJ398 (Infigratinib)	BGJ398 (Infigratinib) is a potent and selective FGFR kinase inhibitor with IC50 values of 0.9 nM, 1.4 nM, 1 nM and 60 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively.
M1721	AZD4547	AZD4547 is a potent, selective and orally active pan-FGFR inhibitor with IC50s of 0.2. 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectively.

Signaling Pathways

Product Type

FGFR Fibroblast Growth Factor Receptor

Get to Know Us

Customer Support

Resources

Contact Us